WEP Group Holdings Limited (WEP Clinical) is pleased to announce the closure of an investment in the company made by The Jordan Company, L.P. (TJC), a middle-market private equity firm. Under the terms of the investment, WEP Clinical co-founders and current Managing Directors, Jaswinder Khera and Jaswant Khera, will continue to be significant owners in the company and will help navigate WEP Clinical through this next phase of growth.

TJC has been investing in companies for over 30 years. The firm targets control investments, principally located in North America, and has contributed to the growth of many businesses representing a wide range of industries. Since 2002, TJC has completed over 250 add-on investments into its portfolio companies.

TJC’s investment approach is to acquire companies in partnership with management. It believes fostering strong relationships with talented and skilled managers is critical to successfully executing a hands-on operating strategy and implementing an add-on acquisition strategy.

Jaswinder Khera, Managing Director US at WEP Clinical, said:

“We couldn’t be more excited to have TJC on board to help us grow and develop as a company. There is a great cultural fit between our organizations, and we share a vision for WEP Clinical’s future. TJC’s resources and experience will enable us to accelerate our long-term growth plan.”

Jaswant Khera, Managing Director EU at WEP Clinical, said:

“With TJC’s strategic and capital assistance, we are confident that WEP Clinical will continue its current track record of success. We believe this partnership will accelerate our organic and inorganic growth initiatives as we continue investing significantly in our people and capabilities to serve our customers.”

Dan Williams, Partner at TJC, said:

“We are honored to partner with the entire WEP Clinical team and join their mission of helping those in need while providing world class support to customers. We see great growth opportunities for the company and look forward to supporting the business as it grows.”

McDermott, Will and Emery LLP acted as legal advisor and Cain Brothers, a division of KeyBanc Capital Markets Inc., acted as financial advisor to WEP Clinical. Kirkland & Ellis LLP acted as legal advisor to TJC.

About WEP Clinical

Established in 2008, WEP Clinical is a specialist pharma services company that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. WEP has offices located in London, United Kingdom; RTP North Carolina, United States; Lisbon, Portugal; and Dublin, Ireland and possess all the necessary licenses to meet drug access and distribution needs across all regions, worldwide. We are passionate about helping those in need. For more information, please visit www.wepclinical.com.

About The Jordan Company

TJC, founded in 1982, is a middle-market private equity firm that has managed funds with original capital commitments in excess of $17 billion and a 39-year track record of investing in and contributing to the growth of many businesses across a wide range of industries including Healthcare & Consumer; Industrials; Technology, Telecom & Utilities; and Transportation & Logistics. The senior investment team has been investing together for over 20 years and it is supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies. Headquartered in New York, TJC also has offices in Chicago and Stamford. For more information, please visit www.thejordancompany.com.